Latest Events

At the AACR Annual Meeting 2026, Cymoplive will showcase advances in cancer science and translational research, highlighting our work in human-relevant drug response and resistance biology. We look forward to engaging with global oncology researchers, clinicians, and industry stakeholders while expanding discussions around precision oncology and building strategic partnerships with collaborators and industry leaders.

During our Silicon Valley Engagement Program, Cymoplive will conduct focused investor and pharmaceutical outreach across the innovation ecosystem. The program will center on fundraising discussions, strategic validation with key stakeholders, and the development of commercial partnerships to accelerate growth and global impact.

Cymoplive will participate in EACR 2026 to engage in high-level scientific exchange focused on cancer plasticity and adaptive resistance. During the meeting, we will connect with academic researchers, biotech innovators, and pharmaceutical leaders to explore validation opportunities and advance strategic research collaborations.

Cymoplive is proud to sponsor the Bioscopy Conference 2026, hosted in Tromsø this summer in the Arctic. This meeting brings together researchers and innovators advancing imaging technologies and biological discovery. Through our sponsorship and participation, we aim to support scientific exchange, strengthen connections within the Nordic research ecosystem, and engage with academic and industry leaders working at the intersection of imaging, translational science, and therapeutic innovation.